Perhaps I can address that, Member.
Yes, we are concerned about the presence of counterfeit drugs. As I'm sure you know, it's an international problem, so we are working with our colleague regulators from around the world on this. We're also working on part of a broader interdepartmental strategy on counterfeit, and we're looking at the kinds of additional measures that we would need to take collectively with other departments.
As you know, there are issues around border entry, so we're working closely with the Canada Border Services Agency and so on.
We really have two levels of work going on. One is thinking in a very broad way about what kinds of strategies we need to put in place to combat counterfeit. Then, day to day, how do we deal with the kinds of border interception issues and intelligence that gets gathered and that we need to act upon?
But you're quite right. It's an emerging global problem, and it's something we need to try to keep on top of.